Clinical Trials Study
Copyright ©The Author(s) 2019.
World J Gastroenterol. May 7, 2019; 25(17): 2110-2121
Published online May 7, 2019. doi: 10.3748/wjg.v25.i17.2110
Figure 3
Figure 3 Cumulative event curves of the recurrence of reflux esophagitis in the probiotics and placebo groups. Probiotics refers to esomeprazole 20 mg b.i.d. and live combined Bacillus subtilis and Enterococcus faecium enteric-coated capsules 500 mg t.i.d. treatment; placebo refers to esomeprazole 20 mg b.i.d. and placebo treatment.